BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 36146746)

  • 1. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
    Ma J; Zhang J; Yan R
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cofactors influence the biological properties of infectious recombinant prions.
    Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J
    Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
    Piro JR; Wang F; Walsh DJ; Rees JR; Ma J; Supattapone S
    Biochemistry; 2011 Aug; 50(33):7111-6. PubMed ID: 21776987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity.
    Wang F; Wang X; Orrú CD; Groveman BR; Surewicz K; Abskharon R; Imamura M; Yokoyama T; Kim YS; Vander Stel KJ; Sinniah K; Priola SA; Surewicz WK; Caughey B; Ma J
    PLoS Pathog; 2017 Jul; 13(7):e1006491. PubMed ID: 28704563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors.
    Kim JI; Cali I; Surewicz K; Kong Q; Raymond GJ; Atarashi R; Race B; Qing L; Gambetti P; Caughey B; Surewicz WK
    J Biol Chem; 2010 May; 285(19):14083-7. PubMed ID: 20304915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious prions and proteinopathies.
    Barron RM
    Prion; 2017 Jan; 11(1):40-47. PubMed ID: 28281925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of recombinant prion autocatalysis from infectivity.
    Noble GP; Supattapone S
    Prion; 2015; 9(6):405-11. PubMed ID: 26645356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-seeding by prion protein inactivates TDP-43.
    Polido SA; Stuani C; Voigt A; Banik P; Kamps J; Bader V; Grover P; Krause LJ; Zerr I; Matschke J; Glatzel M; Winklhofer KF; Buratti E; Tatzelt J
    Brain; 2024 Jan; 147(1):240-254. PubMed ID: 37669322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
    Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
    PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.
    Imamura M; Kato N; Yoshioka M; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
    J Virol; 2011 Mar; 85(6):2582-8. PubMed ID: 21228241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prion Concept and Synthetic Prions.
    Legname G; Moda F
    Prog Mol Biol Transl Sci; 2017; 150():147-156. PubMed ID: 28838659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
    Saá P; Cervenakova L
    Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular aspects of prion replication in vitro.
    Grassmann A; Wolf H; Hofmann J; Graham J; Vorberg I
    Viruses; 2013 Jan; 5(1):374-405. PubMed ID: 23340381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the origin of prion protein misfolding via reconstruction of ancestral proteins.
    Cortez LM; Morrison AJ; Garen CR; Patterson S; Uyesugi T; Petrosyan R; Sekar RV; Harms MJ; Woodside MT; Sim VL
    Protein Sci; 2022 Dec; 31(12):e4477. PubMed ID: 36254680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of Animal Prion Diseases.
    Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.